Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder
Recruiting
Phase 1
Interventional Study
Alcohol Use Disorder
At a Glance
- Age
- 21 – 60
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Newleos Therapeutics, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Disorder (AUD). The main questions this trial aims to answer are:
* Does NTX-2001 affect alcohol consumption in adults with AUD?
* Is NTX-2001 safe and well tolerated in adults with AUD?
Researchers will compare the effects of NTX-2001 with m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Has provided written informed consent for the study and is willing to comply with all requirements of the protocol
2. English speaker
3. Male or female, ≥21 and ≤60 years of age.
4. Has a body mass index (BMI) 18 to 35 kg/m2 inclusive.
5. Meets DSM-5 criteria for Alcohol Use …
Contacts